Private company
Who owns Mozarc Medical
One company in the researched set discloses a stake in Mozarc Medical, worth $0 between them. Mozarc Medical is private, so no 13F reports it: a 13F covers exchange listed positions only. These figures exist because each holder disclosed the stake in its own filings.
Mozarc Medical - Profile
- Type
- joint venture
- Based in
- United States
- Founded
- 2023
Mozarc Medical is a kidney health technology company based at 710 Medtronic Parkway in Minneapolis, Minnesota, formed as an equally owned joint venture of Medtronic and DaVita and launched on 1 April 2023. Its business is Medtronic's former Renal Care Solutions unit, which Medtronic contributed together with that unit's leadership team, while DaVita brought research and development capability from its dialysis clinic operations. Mozarc makes renal access devices and machines used in acute and chronic dialysis, serves markets in the United States, Europe, the Middle East, Africa, Japan and Mexico, and is working on dialysis technology designed for use at home.
Source
Mozarc Medical files nothing with the SEC, so none of this comes from a filer record. The description was written for this site in August 2026 from Medtronic, DaVita launch Mozarc Medical (Medtronic newsroom, 1 April 2023), Mozarc Medical: About us and Medtronic, DaVita launch kidney care joint venture (MedTech Dive). The ownership figures below come from the holders' filings instead, and are sourced row by row.
The disclosed stakes
One row per position. Where a holder reports the same company in two share classes, both rows are shown rather than summed, because the class is part of a position's identity.
Where each figure comes from
A private stake has no ownership form behind it, so the source is always the holder's own filing or disclosure. Anything modelled says so, with the arithmetic.
- Medtronic plc, as of 24 Apr 2026. Medtronic elected the fair value option for this equity-method investment. Cumulative losses of $220m (FY2024), $171m (FY2025) and $140m (FY2026) recognized through earnings reduced the carrying fair value to exactly zero as of fiscal year end April 24, 2026, per the FY2026 10-K Note on 'Equity Securities, Equity Method Investments, and Other Investments' and the dedicated 'Mozarc Medical Investment' disclosure. source
What this page is not
It is not a complete register. It lists the holders who happen to be inside the researched set and disclosed the stake themselves. A private company can have many other shareholders, and nothing here rules them out: venture investors, founders and employees usually appear in no public filing at all. Percentages are of Mozarc Medical where a holder stated one, and are missing where no holder did.